| Literature DB >> 25051410 |
K J Bunch1, T J Vincent1, R J Black2, M S Pearce3, R J Q McNally3, P A McKinney4, L Parker5, A W Craft6, M F G Murphy1.
Abstract
BACKGROUND: Earlier studies have shown raised risks of leukaemia and non-Hodgkin lymphoma in children, teenagers and young adults resident either at birth or diagnosis in Seascale. Some increases in cancer risk in these age groups have also been noted among those living around Dounreay. We aimed to update previous analyses relating to areas close to these nuclear installations by considering data from an additional 16 years of follow-up.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25051410 PMCID: PMC4453720 DOI: 10.1038/bjc.2014.357
Source DB: PubMed Journal: Br J Cancer ISSN: 0007-0920 Impact factor: 7.640
Figure 1The county districts of Cumbria.
Summary of average annual population estimates for study areas
| Period | 0–14 years | 15–24 years | 0–14 years | 15–24 years | 0–14 years | 15–24 years |
| 1963–1983 | 533 | 294 | 38 571 | 24 398 | 67 649 | 33 225 |
| 1984–1990 | 343 | 267 | 30 880 | 24 805 | 56 529 | 36 890 |
| 1991–2006 | 299 | 160 | 29 763 | 18 463 | 56 702 | 27 856 |
| 1963–2006 | 418 | 232 | 34 144 | 21 974 | 61 899 | 31 639 |
1969–1983 for 15–24 age group as cancer incidence data are only available from 1969.
Rest of Cumbria excludes Barrow-in-Furness county district for the 15–24 age group.
Figure 2(
Diagnostic subgroups considered in cross-sectional and cohort analyses
| Total cancer | Total cancer |
| Total leukaemia | Total leukaemia |
| Lymphoid leukaemia | Non-Hodgkin lymphoma |
| Other leukaemia | Hodgkin lymphoma |
| Total leukaemia and non-Hodgkin lymphoma | Brain and CNS tumours |
| Non-Hodgkin lymphoma | Melanoma of the skin |
| Hodgkin lymphoma | Neuroblastoma and ganglioneuroblastoma |
| Brain and CNS tumours | Upper respiratory tract tumours |
| Other solid tumours | Gastrointestinal tract tumours |
| Lower respiratory tract tumours | |
| Breast cancer | |
| Genitourinary tract tumours | |
| Thyroid cancer |
Abbreviation: CNS=central nervous system.
Numbers of observed and expected cases and SIRs for individuals aged 0–14 and 15–24 resident around Sellafield
| 1963–1983 | 4 | 0.41 | 2.68–25.22 | 0 | 0.09 | 0.00 | 0.00–34.44 | |
| 1984–1990 | 1 | 0.10 | 10.28 | 0.26–57.26 | 0 | 0.04 | 0.00 | 0.00–71.99 |
| 1991–2006 | 0 | 0.21 | 0.00 | 0.00–14.07 | 1 | 0.05 | 18.56 | 0.46–103.38 |
| 1963–2006 | 5 | 0.73 | 2.22–15.96 | 1 | 0.18 | 5.47 | 0.14–30.47 | |
| 1963–1983 | 1 | 0.81 | 1.24 | 0.03–6.90 | 0 | 0.57 | 0.00 | 0.00–5.23 |
| 1984–1990 | 1 | 0.20 | 4.95 | 0.13–27.59 | 3 | 0.28 | 2.19–31.02 | |
| 1991–2006 | 1 | 0.46 | 2.19 | 0.06–12.21 | 0 | 0.38 | 0.00 | 0.00–7.85 |
| 1963–2006 | 3 | 1.50 | 1.99 | 0.41–5.83 | 3 | 1.25 | 2.40 | 0.50–7.03 |
| 1963–1983 | 5 | 1.21 | 1.33–9.60 | 0 | 0.66 | 0.00 | 0.00–4.54 | |
| 1984–1990 | 2 | 0.30 | 6.68 | 0.81–24.11 | 3 | 0.32 | 1.91–27.01 | |
| 1991–2006 | 1 | 0.67 | 1.49 | 0.04–8.30 | 1 | 0.44 | 2.30 | 0.06–12.81 |
| 1963–2006 | 8 | 2.23 | 1.54–7.05 | 4 | 1.43 | 2.80 | 0.76–7.17 | |
| 1963–1983 | 22 | 29.37 | 0.75 | 0.47–1.13 | 9 | 6.98 | 1.29 | 0.59–2.45 |
| 1984–1990 | 10 | 8.76 | 1.14 | 0.55–2.10 | 2 | 3.46 | 0.58 | 0.07–2.08 |
| 1991–2006 | 19 | 21.17 | 0.90 | 0.69–1.40 | 6 | 6.19 | 0.97 | 0.36–2.11 |
| 1963–2006 | 51 | 59.61 | 0.86 | 0.64–1.13 | 17 | 16.72 | 1.02 | 0.59–1.63 |
| 1963–1983 | 56 | 58.36 | 0.96 | 0.73–1.25 | 55 | 49.96 | 1.10 | 0.83–1.43 |
| 1984–1990 | 18 | 18.18 | 0.99 | 0.59–1.57 | 30 | 27.51 | 1.09 | 0.74–1.56 |
| 1991–2006 | 46 | 45.39 | 1.01 | 0.74–1.35 | 48 | 45.44 | 1.06 | 0.78–1.40 |
| 1963–2006 | 120 | 122.84 | 0.98 | 0.81–1.17 | 133 | 123.10 | 1.08 | 0.91–1.28 |
| 1963–1983 | 78 | 87.73 | 0.89 | 0.71–1.11 | 64 | 56.94 | 1.12 | 0.87–1.45 |
| 1984–1990 | 28 | 26.93 | 1.04 | 0.69–1.51 | 32 | 30.97 | 1.03 | 0.71–1.46 |
| 1991–2006 | 65 | 66.56 | 0.98 | 0.76–1.26 | 54 | 51.63 | 1.05 | 0.79–1.37 |
| 1963–2006 | 171 | 182.45 | 0.94 | 0.80–1.09 | 150 | 139.82 | 1.07 | 0.91–1.26 |
| 1963–1983 | 52 | 51.50 | 1.01 | 0.76–1.33 | 6 | 9.57 | 0.63 | 0.23–1.37 |
| 1984–1990 | 25 | 16.03 | 1.01–2.31 | 3 | 5.27 | 0.57 | 0.12–1.66 | |
| 1991–2006 | 37 | 40.33 | 0.92 | 0.65–1.27 | 5 | 9.34 | 0.54 | 0.17–1.25 |
| 1963–2006 | 114 | 108.07 | 1.05 | 0.87–1.27 | 14 | 24.19 | 0.32–0.97 | |
| 1963–1983 | 102 | 102.36 | 1.00 | 0.81–1.21 | 63 | 67.43 | 0.93 | 0.72–1.20 |
| 1984–1990 | 30 | 33.27 | 0.90 | 0.61–1.29 | 35 | 40.54 | 0.86 | 0.60–1.20 |
| 1991–2006 | 73 | 86.48 | 0.84 | 0.66–1.06 | 59 | 68.52 | 0.86 | 0.66–1.11 |
| 1963–2006 | 205 | 222.70 | 0.92 | 0.80–1.06 | 157 | 176.23 | 0.89 | 0.76–1.04 |
| 1963–1983 | 154 | 153.861 | 1.00 | 0.85–1.18 | 69 | 77.01 | 0.90 | 0.70–1.14 |
| 1984–1990 | 55 | 49.304 | 1.12 | 0.84–1.46 | 38 | 45.81 | 0.83 | 0.59–1.14 |
| 1991–2006 | 110 | 126.808 | 0.87 | 0.72–1.05 | 64 | 77.86 | 0.82 | 0.64–1.06 |
| 1963–2006 | 319 | 330.763 | 0.96 | 0.86–1.08 | 171 | 200.42 | 0.73–0.99 | |
Abbreviations: CD=county district; CI=confidence interval; EWS=England, Wales and Scotland; NRCT=National Registry of Childhood Tumours; NRYPMDR=Northern Region Young Persons' Malignant Disease Registry; SIRs=standardised incidence ratios. SIRs which differ significantly from 1 are shown in bold (P<0.05), bold and underlined (P<0.01).
Based upon NRCT EWS registrations excluding 86 cases with no postcode.
Based upon registrations from the Northern Region Young Persons Malignant Disease Registry excluding those for Cumbria.
1969–1983 for 15–24 age group as NRYPMDR data are only available from 1969.
NRYPMDR registrations do not cover the CD of Barrow.
Standardised incidence ratios for total cancer and defined diagnostic subgroups 1971–2006 for individuals born in Cumbria during 1950–2006
| Total cancer | 21 | 22.35 | 0.94 | 0.58 | 1.44 | 1573 | 1796.63 | 0.83 | 0.92 | 2637 | 2901.73 | 0.87 | 0.94 | ||
| Leukaemia | 2 | 1.2 | 1.67 | 0.2 | 6.03 | 81 | 102.96 | 0.63 | 0.98 | 151 | 174.57 | 0.86 | 0.73 | 1.01 | |
| Non-Hodgkin lymphoma | 2 | 1.28 | 1.57 | 0.19 | 5.66 | 80 | 101.42 | 0.63 | 0.98 | 133 | 164.07 | 0.68 | 0.96 | ||
| Hodgkin disease | 2 | 0.91 | 2.19 | 0.27 | 7.91 | 71 | 73.05 | 0.97 | 0.76 | 1.23 | 107 | 120.51 | 0.89 | 0.73 | 1.07 |
| CNS/brain tumours | 0 | 1.71 | 0.00 | 0.00 | 1.75 | 122 | 140.65 | 0.87 | 0.72 | 1.04 | 237 | 232.99 | 1.02 | 0.89 | 1.16 |
| Melanoma of the skin | 1 | 1.58 | 0.63 | 0.02 | 3.53 | 109 | 124.29 | 0.88 | 0.72 | 1.06 | 200 | 201.32 | 0.99 | 0.86 | 1.14 |
| Neuroblastoma and ganglioneuroblastoma | 0 | 0.08 | 0.00 | 0.00 | 35.41 | 9 | 8.36 | 1.08 | 0.49 | 0.05 | 15 | 15.07 | 1.00 | 0.56 | 1.64 |
| Mouth, oropharynx, larynx and URT tumours | 1 | 0.73 | 1.37 | 0.04 | 7.61 | 52 | 57.79 | 0.90 | 0.67 | 1.18 | 95 | 91.90 | 1.03 | 0.84 | 1.26 |
| GI tract tumours | 1 | 1.35 | 0.74 | 0.02 | 4.11 | 83 | 106.37 | 0.62 | 0.97 | 146 | 167.67 | 0.87 | 0.74 | 1.02 | |
| Lung, trachea and LRT tumours | 0 | 0.92 | 0.00 | 0.00 | 3.25 | 76 | 73.61 | 1.03 | 0.81 | 1.29 | 103 | 115.90 | 0.89 | 0.73 | 1.08 |
| Breast tumours | 7 | 5.18 | 1.35 | 0.54 | 2.78 | 382 | 413.00 | 0.92 | 0.84 | 1.02 | 576 | 656.99 | 0.81 | 0.95 | |
| GU tumours | 3 | 4.81 | 0.62 | 0.13 | 1.82 | 321 | 381.96 | 0.75 | 0.94 | 562 | 615.97 | 0.84 | 0.99 | ||
| Thyroid cancer | 0 | 0.44 | 0.00 | 0.00 | 6.88 | 30 | 34.74 | 0.86 | 0.58 | 1.23 | 59 | 56.85 | 1.04 | 0.79 | 1.34 |
Abbreviations: CDs=county districts; CIs=confidence intervals; CNS=central nervous system; GI=gastrointestinal; GU=genitourinary; LRT=lower respiratory tract; SIR=standardised incidence ratio; URT=upper respiratory tract. SIRs which differ significantly from 1 are shown in bold (P<0.05), bold and underlined (P<0.01) and bold and double underlined (P<0.001).
CIs based on exact CIs for Poisson counts.
Numbers of observed and expected cases and SIRs for individuals aged 0–14 and 15–24 resident around Dounreay during 1963–2006
| 1963–1983 | 5 | 2.14 | 2.33 | 0.75–5.43 | 0 | 0.65 | 0.00 | 0.00–4.60 |
| 1984–1990 | 1 | 0.59 | 1.71 | 0.04–9.52 | 2 | 0.22 | 1.12–33.28 | |
| 1991–2006 | 0 | 1.24 | 0.00 | 0.00–2.41 | 0 | 0.55 | 0.00 | 0.00–5.46 |
| 1963–2006 | 6 | 4.03 | 1.49 | 0.55–3.25 | 2 | 1.43 | 1.40 | 0.17–5.05 |
| 1963–1983 | 2 | 4.26 | 0.47 | 0.06–1.70 | 4 | 5.26 | 0.76 | 0.21–1.95 |
| 1984–1990 | 0 | 1.22 | 0.00 | 0.00–2.46 | 3 | 2.18 | 1.37 | 0.28–4.02 |
| 1991–2006 | 2 | 2.66 | 0.75 | 0.09–2.71 | 5 | 4.71 | 1.06 | 0.34–2.48 |
| 1963–2006 | 4 | 8.31 | 0.48 | 0.13–1.23 | 12 | 12.26 | 0.98 | 0.51–1.71 |
| 1963–1983 | 7 | 6.41 | 1.09 | 0.44–2.25 | 4 | 5.91 | 0.68 | 0.18–1.74 |
| 1984–1990 | 1 | 1.80 | 0.55 | 0.01–3.06 | 5 | 2.40 | 2.08 | 0.67–4.85 |
| 1991–2006 | 2 | 3.91 | 0.51 | 0.06–1.84 | 5 | 5.26 | 0.95 | 0.31–2.21 |
| 1963–2006 | 10 | 12.34 | 0.81 | 0.39–1.49 | 14 | 13.69 | 1.02 | 0.56–1.71 |
| 1963–1983 | 5 | 3.27 | 1.53 | 0.50–3.56 | 0 | 1.02 | 0.00 | 0.00–2.95 |
| 1984–1990 | 3 | 1.02 | 2.93 | 0.60–8.56 | 0 | 0.34 | 0.00 | 0.00–8.85 |
| 1991–2006 | 0 | 2.27 | 0.00 | 0.00–1.32 | 0 | 0.91 | 0.00 | 0.00–3.31 |
| 1963–2006 | 8 | 6.61 | 1.21 | 0.52–2.38 | 0 | 2.27 | 0.00 | 0.00–1.32 |
| 1963–1983 | 5 | 6.50 | 0.77 | 0.25–1.80 | 5 | 8.22 | 0.61 | 0.20–1.42 |
| 1984–1990 | 1 | 2.12 | 0.47 | 0.01–2.63 | 3 | 3.41 | 0.88 | 0.18–2.57 |
| 1991–2006 | 6 | 4.86 | 1.23 | 0.45–2.69 | 4 | 7.77 | 0.51 | 0.14–1.32 |
| 1963–2006 | 12 | 13.61 | 0.88 | 0.46–1.54 | 12 | 19.48 | 0.62 | 0.32–1.08 |
| 1963–1983 | 10 | 9.77 | 1.02 | 0.49–1.88 | 5 | 9.24 | 0.54 | 0.17–1.26 |
| 1984–1990 | 4 | 3.15 | 1.27 | 0.35–3.25 | 3 | 3.75 | 0.80 | 0.16–2.34 |
| 1991–2006 | 6 | 7.13 | 0.84 | 0.31–1.83 | 4 | 8.68 | 0.46 | 0.13–1.18 |
| 1963–2006 | 20 | 20.22 | 0.99 | 0.60–1.52 | 12 | 21.74 | 0.28–0.96 | |
Abbreviations: CI=confidence interval; EWS=England, Wales and Scotland; NRCT=National Registry of Childhood Tumours; SIR=standardised incidence ratio. SIRs which differ significantly from 1 are shown in bold (P<0.05).
Expectations and SIRs based on NRCT EWS registrations excluding 86 cases with no postcode.
Expectations and SIRs based on Scottish registrations from the General Register Office for Scotland.
Total cancer incidence within the Dounreay birth cohort
| 5 | 3656 | 2 | 99.95 | 99.79 | 99.99 |
| 10 | 3370 | 2 | 99.95 | 99.79 | 99.99 |
| 15 | 3063 | 3 | 99.92 | 99.74 | 99.97 |
| 25 | 2238 | 12 | 99.57 | 99.24 | 99.76 |
| 35 | 1496 | 23 | 98.95 | 98.40 | 99.31 |
| 45 | 513 | 34 | 97.86 | 96.89 | 98.54 |
| 55 | 45 | 42 | 92.71 | 87.03 | 95.96 |
| 5 | 3844 | 3 | 99.92 | 99.77 | 99.98 |
| 10 | 3535 | 5 | 99.87 | 99.69 | 99.95 |
| 15 | 3196 | 7 | 99.81 | 99.60 | 99.91 |
| 25 | 2444 | 14 | 99.57 | 99.27 | 99.75 |
| 35 | 1693 | 26 | 99.00 | 98.51 | 99.32 |
| 45 | 688 | 37 | 98.01 | 97.15 | 98.61 |
| 55 | 85 | 51 | 93.26 | 89.39 | 95.75 |
Abbreviations: CI=confidence interval. Log-rank test for equality of survivor functions gives a Chi squared statistic of 0 on 1 degree of freedom (P=0.99).